Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Voyageur Pharmaceuticals Ltd. (V:VM)

Business Focus: Pharmaceuticals

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for VM within the last 6 months
See all filings within the past 6 months

Company News

Jan 18, 2021 07:01 ET
Voyageur Pharmaceuticals Ltd. Announces Second and Final Closing of Private Placement and Future Director Retirement
Calgary, Alberta - TheNewswire - December January 15, 2021 - Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has completed the second and final closing of its previously announced non-brokered private placement of units (the "Offering").  The Company issued 4,300,000 Common Units (as defined below) in the second closing, resulting in a total number of 15,650,000 units being issued under the Offering, for total gross proceeds of $782,500, representing an increase of $82,500 to the maximum Offering amount previously announced.
Read full article
Dec 31, 2020 07:12 ET
Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement and First Closing
Calgary, Alberta - TheNewswire - December 31, 2020 – Voyageur Pharmaceuticals Ltd. (TSXV:VM) (OTC:VYYRF) (the "Company" or "Voyageur") is pleased to announce that it has increased the previously announced non-brokered offering of units (the "Offering") from a maximum of $600,000 to $700,000.  In addition, the Company announces that it has completed the first closing under the Offering by issuing 11,350,000 units for gross proceeds of $567,500.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 202018,6100
Nov 30, 20204,643-16,157
Nov 15, 202020,8000
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Voyageur Pharmaceuticals Ltd., formerly Voyageur Minerals Ltd., is an exploration stage pharmaceutical company. The Company is focused on manufacturing mineral based pharmaceutical products. The Company is engaged in the acquisition, exploration and evaluation of pharmaceutical mineral resource properties. It has interests in five mineral properties located in the province of British Colombia, Canada and the state of Utah, United States of America.

See business summary



Search (past week) for $VM.CA VM.V

  • No tweets found